These findings highlight the potential of naringenin to bind stably with both JAK1 and STAT1, supporting its proposed involvement in modulating the JAK-STAT signaling axis and contributing to the observed anti-melanoma activity of MBP. The gene discussed is SOAT1; the disease is melanoma.